186 related articles for article (PubMed ID: 9837851)
1. Modulating the immune response to genetic immunization.
Cohen AD; Boyer JD; Weiner DB
FASEB J; 1998 Dec; 12(15):1611-26. PubMed ID: 9837851
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
5. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
Hoffman SL; Doolan DL
Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
[TBL] [Abstract][Full Text] [Related]
6. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
7. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies using DNA for the induction of mucosal immunity.
McCluskie MJ; Davis HL
Crit Rev Immunol; 1999; 19(4):303-29. PubMed ID: 10530431
[TBL] [Abstract][Full Text] [Related]
10. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
12. Designing immune responses with genetic immunization and immunostimulatory DNA sequences.
Thalhamer J; Leitner W; Hammerl P; Brtko J
Endocr Regul; 2001 Sep; 35(3):143-66. PubMed ID: 11674843
[TBL] [Abstract][Full Text] [Related]
13. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
Encke J; zu Putlitz J; Stremmel W; Wands JR
Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
[TBL] [Abstract][Full Text] [Related]
14. Expression library immunization to discover and improve vaccine antigens.
Barry MA; Howell DP; Andersson HA; Chen JL; Singh RA
Immunol Rev; 2004 Jun; 199():68-83. PubMed ID: 15233727
[TBL] [Abstract][Full Text] [Related]
15. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
16. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.
Stan AC; Casares S; Brumeanu TD; Klinman DM; Bona CA
Eur J Immunol; 2001 Jan; 31(1):301-10. PubMed ID: 11265647
[TBL] [Abstract][Full Text] [Related]
17. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
[TBL] [Abstract][Full Text] [Related]
18. Potential advantages of DNA immunization for influenza epidemic and pandemic planning.
Webster RG
Clin Infect Dis; 1999 Feb; 28(2):225-9. PubMed ID: 10064231
[TBL] [Abstract][Full Text] [Related]
19. Gene vaccination for the induction of immune tolerance.
Ferrera F; La Cava A; Rizzi M; Hahn BH; Indiveri F; Filaci G
Ann N Y Acad Sci; 2007 Sep; 1110():99-111. PubMed ID: 17911425
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.
Castaldello A; Sgarbanti M; Marsili G; Brocca-Cofano E; Remoli AL; Caputo A; Battistini A
J Cell Physiol; 2010 Sep; 224(3):702-9. PubMed ID: 20432465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
